Atypical ubiquitin-binding protein SHARPIN promotes breast cancer progression

•Ubiquitination plays an important role in the development of breast cancer.•SHARPIN promotes normal tissue development, inflammation and homeostasis.•SHARPIN as a ubiquitin-related protein, can promote breast cancer through P53 and ER signaling pathways. Breast cancer ranks first among female malig...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedicine & pharmacotherapy 2019-11, Vol.119, p.109414, Article 109414
Hauptverfasser: Tian, Zelin, Tang, Jianing, Yang, Qian, Li, Xin, Zhu, Jian, Wu, Gaosong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Ubiquitination plays an important role in the development of breast cancer.•SHARPIN promotes normal tissue development, inflammation and homeostasis.•SHARPIN as a ubiquitin-related protein, can promote breast cancer through P53 and ER signaling pathways. Breast cancer ranks first among female malignancies worldwide, and estrogen receptor-positive (ER+) breast cancer is the leading cause of cancer death in women. Abnormal oncogenic signaling has important effects on the development of breast cancer, such as ERα/ ESR1 (estrogen receptor alpha), PTEN (gene of phosphate and tension homology deleted on chromsome ten), NFκB(nuclear factor κB), and tumor protein p53 (p53 / TP53). SHARPIN is a ubiquitin-related protein that has important regulatory functions in inflammation control, immune organ development, and cancer development. SHARPIN is highly expressed in many cancers, especially in breast cancer. It plays an important role in controlling important carcinogenic pathways in breast cancer, such as p53 and ERα. This review emphasizes the functional role of SHARPIN and the recent advances in the molecular mechanisms by which SHARPIN regulates breast cancer development through ubiquitination.
ISSN:0753-3322
1950-6007
DOI:10.1016/j.biopha.2019.109414